Related Experiment Video
Updated: Jun 25, 2026

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
Mitochondria as targets for chemotherapy
Vladimir Gogvadze1, Sten Orrenius, Boris Zhivotovsky
1Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Vladimir.Gogvadze@ki.se
Abstract:
Mitochondrial malfunctioning is implicated in the pathogenesis of a variety of disorders, including cancer and multiple neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease. Disturbance of mitochondrial vital functions, e.g., production of ATP, calcium buffering capacity, and generation of reactive oxygen species, can be potentially involved in disease pathogenesis. Neurological disorders caused by mitochondrial deterioration are often associated with cell loss within specific brain regions. In contrast, mitochondrial alterations in tumor cells and the "Warburg effect" might lead to cell survival and resistance of tumor cells to chemotherapy. This review is devoted to the role of mitochondria in neurodegeneration and tumor formation, and describes how targeting of mitochondria can be beneficial in the therapy of these diseases, which affect a large human population.
Insights
Mitochondrial dysfunction contributes to neurodegenerative diseases and cancer. Targeting mitochondria offers potential therapeutic strategies for these widespread conditions.
Area of Science:
- Cell Biology
- Neuroscience
- Oncology
Background:
- Mitochondrial malfunctioning is a key factor in numerous diseases.
- Disruptions in ATP production, calcium buffering, and reactive oxygen species generation by mitochondria are implicated in pathogenesis.
- Neurological disorders often involve mitochondrial deterioration and specific brain region cell loss.
Purpose of the Study:
- To review the role of mitochondria in neurodegeneration and tumor formation.
- To explore the potential of targeting mitochondria for therapeutic benefit.
Main Methods:
- Literature review of mitochondrial roles in disease.
- Analysis of mitochondrial functions in cancer and neurodegenerative disease contexts.
Main Results:
- Mitochondrial dysfunction is central to neurodegenerative diseases like Parkinson's, Alzheimer's, ALS, and Huntington's.
- The Warburg effect in tumor cells, linked to mitochondrial alterations, promotes survival and chemoresistance.
- Mitochondrial pathways are critical in both disease states.
Conclusions:
- Mitochondria play a dual role in health and disease, impacting neurodegeneration and cancer.
- Therapeutic strategies targeting mitochondria show promise for treating these prevalent human diseases.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Destabilize Microtubules

